Trial Profile
A study to evaluate the efficacy of low dose nakinra for the prophylactic use in patient with sever tophaceous gout.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Gout
- Focus Therapeutic Use
- 11 Sep 2015 New trial record